换一批Predictive value of the flow cytometric PCNA assay (proliferating cell nuclear antigen) in head and neck tumors after accelerated-hyperfractionated radiochemotherapy.
第一作者：
F,Wenz
第一单位：
Department of Clinical Radiology, University of Heidelberg, Germany.
作者：
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤药(Antineoplastic Agents);癌, 鳞状细胞(Carcinoma, Squamous Cell);顺铂(Cisplatin);综合疗法(Combined Modality Therapy);DNA, 肿瘤(DNA, Neoplasm);无病生存(Disease-Free Survival);女(雌)性(Female);流式细胞术(Flow Cytometry);头颈部肿瘤(Head and Neck Neoplasms);人类(Humans);男(雄)性(Male);中年人(Middle Aged);肿瘤蛋白质类(Neoplasm Proteins);肿瘤分期(Neoplasm Staging);倍性(Ploidies);试验预期值(Predictive Value of Tests);增殖细胞核抗原(Proliferating Cell Nuclear Antigen);前瞻性研究(Prospective Studies);辐射增敏药(Radiation-Sensitizing Agents);放射治疗剂量(Radiotherapy Dosage)
DOI
10.1016/s0360-3016(97)00024-2
PMID
9128950
发布时间
2019-07-08
- 浏览26
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
